vs
Organogenesis Holdings Inc.（ORGO）与Ouster, Inc.（OUST）财务数据对比。点击上方公司名可切换其他公司
Ouster, Inc.的季度营收约是Organogenesis Holdings Inc.的1.3倍（$48.6M vs $37.2M），Ouster, Inc.同比增速更快（48.9% vs -57.1%），过去两年Ouster, Inc.的营收复合增速更高（34.2% vs -46.5%）
Organogenesis Holdings Inc.是一家领先的再生医学企业，专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品，主要服务美国及部分国际市场的医疗机构与患者，提供经临床验证的医疗解决方案。
Ouster, Inc.是总部位于美国加利福尼亚州旧金山的激光雷达技术企业，主打高分辨率数字化3D激光雷达传感器，产品广泛应用于自动驾驶车辆、工业自动化、机器人、无人机、地图测绘、国防及安防等领域。
ORGO vs OUST — 直观对比
营收规模更大
OUST
是对方的1.3倍
$37.2M
营收增速更快
OUST
高出105.9%
-57.1%
两年增速更快
OUST
近两年复合增速
-46.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $37.2M | $48.6M |
| 净利润 | — | $4.0M |
| 毛利率 | 30.8% | 42.9% |
| 营业利润率 | -185.1% | 17.6% |
| 净利率 | — | 8.2% |
| 营收同比 | -57.1% | 48.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ORGOOUST
| Q1 26 | $37.2M | $48.6M | ||
| Q4 25 | $225.6M | $62.2M | ||
| Q3 25 | $150.9M | $39.5M | ||
| Q2 25 | $101.0M | $35.0M | ||
| Q1 25 | $86.7M | $32.6M | ||
| Q4 24 | $126.7M | $30.1M | ||
| Q3 24 | $115.2M | $28.1M | ||
| Q2 24 | $130.2M | $27.0M |
净利润ORGOOUST
| Q1 26 | — | $4.0M | ||
| Q4 25 | $43.7M | — | ||
| Q3 25 | $21.6M | $-21.7M | ||
| Q2 25 | $-9.4M | $-20.6M | ||
| Q1 25 | $-18.8M | $-22.0M | ||
| Q4 24 | $7.7M | — | ||
| Q3 24 | $12.3M | $-25.6M | ||
| Q2 24 | $-17.0M | $-23.9M |
毛利率ORGOOUST
| Q1 26 | 30.8% | 42.9% | ||
| Q4 25 | — | 60.2% | ||
| Q3 25 | — | 42.1% | ||
| Q2 25 | — | 45.2% | ||
| Q1 25 | 72.6% | 41.3% | ||
| Q4 24 | 75.5% | 43.8% | ||
| Q3 24 | 76.7% | 38.3% | ||
| Q2 24 | 77.6% | 33.7% |
营业利润率ORGOOUST
| Q1 26 | -185.1% | 17.6% | ||
| Q4 25 | 28.1% | 1.5% | ||
| Q3 25 | 13.7% | -61.4% | ||
| Q2 25 | -12.5% | -76.5% | ||
| Q1 25 | -30.9% | -73.0% | ||
| Q4 24 | 8.1% | -85.1% | ||
| Q3 24 | 5.4% | -98.0% | ||
| Q2 24 | -10.7% | -93.6% |
净利率ORGOOUST
| Q1 26 | — | 8.2% | ||
| Q4 25 | 19.4% | — | ||
| Q3 25 | 14.3% | -55.0% | ||
| Q2 25 | -9.3% | -58.8% | ||
| Q1 25 | -21.7% | -67.5% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 10.7% | -91.1% | ||
| Q2 24 | -13.1% | -88.4% |
每股收益（稀释后）ORGOOUST
| Q1 26 | — | $0.06 | ||
| Q4 25 | $0.31 | $0.10 | ||
| Q3 25 | $0.11 | $-0.37 | ||
| Q2 25 | $-0.10 | $-0.38 | ||
| Q1 25 | $-0.17 | $-0.42 | ||
| Q4 24 | $0.05 | $-0.46 | ||
| Q3 24 | $0.09 | $-0.54 | ||
| Q2 24 | $-0.13 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $91.4M | $173.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $275.6M |
| 总资产 | $520.0M | $381.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ORGOOUST
| Q1 26 | $91.4M | $173.1M | ||
| Q4 25 | $93.7M | $208.6M | ||
| Q3 25 | $63.7M | $244.5M | ||
| Q2 25 | $73.1M | $226.5M | ||
| Q1 25 | $110.0M | $168.2M | ||
| Q4 24 | $135.6M | $172.0M | ||
| Q3 24 | $94.3M | $151.4M | ||
| Q2 24 | $89.9M | $184.2M |
总债务ORGOOUST
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $62.3M | — | ||
| Q2 24 | $63.8M | — |
股东权益ORGOOUST
| Q1 26 | — | $275.6M | ||
| Q4 25 | $300.1M | $261.7M | ||
| Q3 25 | $255.1M | $247.4M | ||
| Q2 25 | $233.2M | $221.0M | ||
| Q1 25 | $242.9M | $167.9M | ||
| Q4 24 | $262.9M | $180.9M | ||
| Q3 24 | $278.5M | $171.7M | ||
| Q2 24 | $263.5M | $170.6M |
总资产ORGOOUST
| Q1 26 | $520.0M | $381.5M | ||
| Q4 25 | $598.7M | $349.5M | ||
| Q3 25 | $509.8M | $353.8M | ||
| Q2 25 | $461.1M | $321.8M | ||
| Q1 25 | $467.4M | $268.6M | ||
| Q4 24 | $497.9M | $276.1M | ||
| Q3 24 | $446.3M | $255.2M | ||
| Q2 24 | $443.2M | $309.9M |
负债/权益比ORGOOUST
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ORGO
暂无分部数据
OUST
| Product revenue | $48.2M | 99% |
| Royalties | $347.0K | 1% |
